Giant Biogene Holding Co (HKSE:02367) Interest Coverage : 17,186.92 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Giant Biogene Holding Co's Operating Income for the six months ended in Dec. 2023 was HK$1,031 Mil. Giant Biogene Holding Co's Interest Expense for the six months ended in Dec. 2023 was HK$-0 Mil. Giant Biogene Holding Co's interest coverage for the quarter that ended in Dec. 2023 was 17,186.92. The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Giant Biogene Holding Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

The historical rank and industry rank for Giant Biogene Holding Co's Interest Coverage or its related term are showing as below:

HKSE:02367' s Interest Coverage Range Over the Past 10 Years
Min: No Debt Med: No Debt Max: 57225.57
Current: 14926.26

HKSE:02367's Interest Coverage is ranked better than
99.64% of 1370 companies
in the Consumer Packaged Goods industry
Industry Median: 8.395 vs HKSE:02367: 14926.26

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Giant Biogene Holding Co Interest Coverage Historical Data

The historical data trend for Giant Biogene Holding Co's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Giant Biogene Holding Co Interest Coverage Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Coverage

No Debt

57,225.57

14,804.90

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Coverage	Get a 7-Day Free Trial			No Debt	No Debt	32,625.74	12,738.53	17,186.92

Competitive Comparison of Giant Biogene Holding Co's Interest Coverage

For the Household & Personal Products subindustry, Giant Biogene Holding Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Giant Biogene Holding Co's Interest Coverage Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Giant Biogene Holding Co's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Giant Biogene Holding Co's Interest Coverage falls into.

Giant Biogene Holding Co Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage

-1

Operating Income

Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt ⁽¹⁾.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Giant Biogene Holding Co's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Giant Biogene Holding Co's Interest Expense was HK$-0 Mil. Its Operating Income was HK$1,821 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$1 Mil.

Interest Coverage	=	-1	*	Operating Income (A: Dec. 2023 )	/	Interest Expense (A: Dec. 2023 )
	=	-1	*	1821.003	/	-0.123
	=	14,804.90

Giant Biogene Holding Co's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Here, for the six months ended in Dec. 2023, Giant Biogene Holding Co's Interest Expense was HK$-0 Mil. Its Operating Income was HK$1,031 Mil. And its Long-Term Debt & Capital Lease Obligation was HK$1 Mil.

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	1031.215	/	-0.06
	=	17,186.92

The higher the ratio, the stronger the company's Financial Strength is.

Giant Biogene Holding Co (HKSE:02367) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Giant Biogene Holding Co Interest Coverage Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Interest Coverage

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines